Manufacturing

Stevanato Group will support development and production of pre-fillable syringes for use in Recipharm’s soft mist inhalers.

Webinar Date/Time: Tue, Apr 18, 2023 11:00 AM EDT

Sandoz, a Novartis division, is expected to invest at least $400 million to build a new biologics manufacturing facility in Lendava, Slovenia, to support growing demand for biosimilars.

Under a technology licensing agreement with Bhami Research Laboratory, Catalent intends to develop formulations that will allow for the delivery of high-concentration biologics subcutaneously.

Manual aseptic operations make quality practices necessary in the manufacturing of compounded drugs.

Catalent is expanding its UpTempo AAV platform to accelerate the development of gene therapies.

Webinar Date/Time: Tuesday, April 4th, 2023 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST

Actylis new 30,000-ft² API manufacturing facility is located in Eugene, Ore.

Webinar Date/Time: Thu, Apr 6, 2023 11:00 AM EDT

PAT is crucial to process control and real-time release in continuous manufacturing of solid-dosage drugs.

Shifts in pharmaceutical packaging have spurred tremendous growth in the pre-filled syringe fill/finish industry.

Stockpiling excess inventory is no longer enough to respond to supply chain volatility.

Technological advances will help ease pressure on pharma supply chains, allowing for greater visibility and less uncertainty.

The trends shaping the growth of the biologics outsourcing industry demand attention.

The ROSS PDDM Planetary Dual Disperser offers flexibility in the form of removable disperser shafts.

Fluid Air’s Enhanced Magnaflo filter blowback system is designed to increase powder yield in PolarDry Models 001 and 004.

The IsoPick from iotaSciences is designed to expand handling solutions for cell biology and gene therapy applications.

Charles River’s HCP-ELISA kit is designed to increase the efficiency and efficacy of HCP assay development.

Key challenges posed to autologous and allogeneic treatments could be resolved by in-vivo CAR-T gene therapies.

AbbVie and Capsida have expanded their existing collaboration to advance three new gene therapy programs.

Agilent’s therapeutic nucleic acids facility gains architectural design support from CRB.

Webinar Date/Time: Thu, Mar 23, 2023 11:00 AM EDT

In this paper, the authors lay out some commonly accepted HCP analytical methods, the challenges of HCP assay, and provide recommendations on what can easily be accomplished in-house and when it may be better to outsource.

To prepare for emerging mRNA technologies, it is necessary to adapt fill/finish and cold chain capabilities.

Webinar Date/Time: Wed, Mar 1, 2023 11:00 AM EST

The complexity of the pharmaceutical product brings challenges to the transfer of information and technology between sponsors and contractors.

Although new single-use technologies offer the flexibility needed to overcome several challenges in ATMP production, there are many considerations and hurdles manufacturers must be aware of when scaling.

Webinar Date/Time: Tue, Feb 28, 2023 2:00 PM EST

Webinar Date/Time: Thu, Feb 23, 2023 11:00 AM EST

Webinar Date/Time: Tuesday, February 28th, 2023 at 11am EST | 8am PST | 4pm GMT | 5pm CET